WAVE Life Sciences (WVE) Tops Q3 EPS by 51c

WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of ($0.12), $0.51 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $36.4 million versus the consensus estimate of $10.36 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c